Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
16.76
-0.07 (-0.42%)
May 13, 2026, 4:00 PM EDT - Market closed
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $181.4 million as of May 13, 2026. Its market cap has increased by 512.90% in one year.
Market Cap
181.40M
Enterprise Value
118.82M
1-Year Change
512.90%
Ranking
Category
Stock Price
$16.76
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $181.40M, a decrease of -92.76%. That is a compound annual growth rate of -35.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 177.49M | -18.19% |
| Dec 31, 2025 | 216.95M | 213.30% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Personalis | 608.43M |
| Castle Biosciences | 575.97M |
| Fulgent Genetics | 447.59M |
| Myriad Genetics | 394.79M |
| Prenetics Global | 292.73M |
| Biodesix | 159.67M |
| Insight Molecular Diagnostics | 158.53M |
| FONAR | 123.57M |